Symbol: |
BVES
|
Description: |
blood vessel epicardial substance [Source:HGNC Symbol;Acc:1152]
|
Location: |
Chr6:105544697-105585049[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:296
Gene |
Compound |
Gen_sig |
Exp_pattern |
BVES |
Camptothecin hemisuccinate sodium salt |
0.012 |
Down |
BVES |
Camptothecin lysinate HCl |
0.01 |
Down |
BVES |
6H-Pyrido[4,3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-, (SP-4-1)-tetrachloroplatinate(2-) (2:1) |
0.031 |
Down |
BVES |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.013 |
Down |
BVES |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.001 |
Down |
BVES |
4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- |
0.048 |
Up |
BVES |
NSC 62349 |
0.025 |
Down |
BVES |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.013 |
Up |
BVES |
ANTINEOPLASTIC-625543 |
0.005 |
Up |
BVES |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-, hydrochloride |
0.011 |
Up |
BVES |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.021 |
Down |
BVES |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.002 |
Down |
BVES |
Naphthalene-1,2-dione, 1,2-dihydro- 4-[(2-phenylethyl)amino]- |
0.012 |
Down |
BVES |
(E)Methyl-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoate |
0.032 |
Down |
BVES |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride |
0.006 |
Up |
Expression pattern: Sensitivity / Resistance
Total:20 Current:4
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:110
Total:8 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:37
Total:3 Current:1
[First] [Prev]  Next Last 
|